1. Home
  2. OSS vs QNCX Comparison

OSS vs QNCX Comparison

Compare OSS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OSS

One Stop Systems Inc.

HOLD

Current Price

$7.84

Market Cap

150.4M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$4.40

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
QNCX
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.4M
139.2M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
OSS
QNCX
Price
$7.84
$4.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$8.50
$7.75
AVG Volume (30 Days)
665.1K
1.1M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,264,017.00
N/A
Revenue This Year
$18.00
N/A
Revenue Next Year
$9.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.33
N/A
52 Week Low
$1.85
$0.72
52 Week High
$7.92
$4.46

Technical Indicators

Market Signals
Indicator
OSS
QNCX
Relative Strength Index (RSI) 76.57 81.05
Support Level $5.81 $3.74
Resistance Level $7.92 $4.30
Average True Range (ATR) 0.50 0.45
MACD 0.28 0.12
Stochastic Oscillator 97.87 96.49

Price Performance

Historical Comparison
OSS
QNCX

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: